These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

460 related articles for article (PubMed ID: 19171042)

  • 1. Autocrine regulation of cell proliferation by estrogen receptor-alpha in estrogen receptor-alpha-positive breast cancer cell lines.
    Tan H; Zhong Y; Pan Z
    BMC Cancer; 2009 Jan; 9():31. PubMed ID: 19171042
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Estrogen receptor alpha is cell cycle-regulated and regulates the cell cycle in a ligand-dependent fashion.
    JavanMoghadam S; Weihua Z; Hunt KK; Keyomarsi K
    Cell Cycle; 2016 Jun; 15(12):1579-90. PubMed ID: 27049344
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Protein kinase D1 regulates ERα-positive breast cancer cell growth response to 17β-estradiol and contributes to poor prognosis in patients.
    Karam M; Bièche I; Legay C; Vacher S; Auclair C; Ricort JM
    J Cell Mol Med; 2014 Dec; 18(12):2536-52. PubMed ID: 25287328
    [TBL] [Abstract][Full Text] [Related]  

  • 4. RASSF1A inhibits estrogen receptor alpha expression and estrogen-independent signalling: implications for breast cancer development.
    Thaler S; Schmidt M; Schad A; Sleeman JP
    Oncogene; 2012 Nov; 31(47):4912-22. PubMed ID: 22266866
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Estrogen receptor α mediates proliferation of breast cancer MCF-7 cells via a p21/PCNA/E2F1-dependent pathway.
    Liao XH; Lu DL; Wang N; Liu LY; Wang Y; Li YQ; Yan TB; Sun XG; Hu P; Zhang TC
    FEBS J; 2014 Feb; 281(3):927-42. PubMed ID: 24283290
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Benzopyran derivative CDRI-85/287 induces G2-M arrest in estrogen receptor-positive breast cancer cells via modulation of estrogen receptors α- and β-mediated signaling, in parallel to EGFR signaling and suppresses the growth of tumor xenograft.
    Saxena R; Fatima I; Chandra V; Blesson CS; Kharkwal G; Hussain MK; Hajela K; Roy BG; Dwivedi A
    Steroids; 2013 Nov; 78(11):1071-86. PubMed ID: 23891847
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Transcription factor Ets1 cooperates with estrogen receptor α to stimulate estradiol-dependent growth in breast cancer cells and tumors.
    Kalet BT; Anglin SR; Handschy A; O'Donoghue LE; Halsey C; Chubb L; Korch C; Duval DL
    PLoS One; 2013; 8(7):e68815. PubMed ID: 23874775
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Harmful effect of ERβ on BCRP-mediated drug resistance and cell proliferation in ERα/PR-negative breast cancer.
    Li W; Jia M; Qin X; Hu J; Zhang X; Zhou G
    FEBS J; 2013 Dec; 280(23):6128-40. PubMed ID: 24103091
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Studies on the development of resistance to the pure antiestrogen Faslodex in three human breast cancer cell lines.
    Sommer A; Hoffmann J; Lichtner RB; Schneider MR; Parczyk K
    J Steroid Biochem Mol Biol; 2003 May; 85(1):33-47. PubMed ID: 12798355
    [TBL] [Abstract][Full Text] [Related]  

  • 10. FOXM1 is a transcriptional target of ERalpha and has a critical role in breast cancer endocrine sensitivity and resistance.
    Millour J; Constantinidou D; Stavropoulou AV; Wilson MS; Myatt SS; Kwok JM; Sivanandan K; Coombes RC; Medema RH; Hartman J; Lykkesfeldt AE; Lam EW
    Oncogene; 2010 May; 29(20):2983-95. PubMed ID: 20208560
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The role of estrogen receptor alpha in mediating chemoresistance in breast cancer cells.
    Jiang Z; Guo J; Shen J; Jin M; Xie S; Wang L
    J Exp Clin Cancer Res; 2012 May; 31(1):42. PubMed ID: 22553917
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Different epigenetic mechanisms of ERα implicated in the fate of fulvestrant-resistant breast cancer.
    Tsuboi K; Kaneko Y; Nagatomo T; Fujii R; Hanamura T; Gohno T; Yamaguchi Y; Niwa T; Hayashi SI
    J Steroid Biochem Mol Biol; 2017 Mar; 167():115-125. PubMed ID: 27888136
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Signal transducer and activator of transcription 5b, c-Src, and epidermal growth factor receptor signaling play integral roles in estrogen-stimulated proliferation of estrogen receptor-positive breast cancer cells.
    Fox EM; Bernaciak TM; Wen J; Weaver AM; Shupnik MA; Silva CM
    Mol Endocrinol; 2008 Aug; 22(8):1781-96. PubMed ID: 18550772
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A novel taspine derivative, HMQ1611, inhibits breast cancer cell growth via estrogen receptor α and EGF receptor signaling pathways.
    Zhan Y; Zhang Y; Liu C; Zhang J; Smith WW; Wang N; Chen Y; Zheng L; He L
    Cancer Prev Res (Phila); 2012 Jun; 5(6):864-73. PubMed ID: 22496388
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The G-protein-coupled estrogen receptor, a gene co-expressed with ERα in breast tumors, is regulated by estrogen-ERα signalling in ERα positive breast cancer cells.
    Pal U; Manjegowda MC; Singh N; Saikia S; Philip BS; Jyoti Kalita D; Kumar Rai A; Sarma A; Raphael V; Modi D; Chandra Kataki A; Mukund Limaye A
    Gene; 2023 Aug; 877():147548. PubMed ID: 37279863
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Estrogen receptor α attenuates therapeutic efficacy of paclitaxel on breast xenograft tumors.
    Chang J; Sui M; Fan W
    Breast Cancer Res Treat; 2012 Aug; 134(3):969-80. PubMed ID: 22374518
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Metalloestrogenic effects of cadmium are absent in long-term estrogen-deprived MCF-7 cells: Evidence for the involvement of constitutively activated estrogen receptor α and very low expression of G protein-coupled estrogen receptor 1.
    Hirao-Suzuki M; Takeda S; Kodama Y; Takiguchi M; Toda A; Ohara M
    Toxicol Lett; 2020 Feb; 319():22-30. PubMed ID: 31689473
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The G protein-coupled receptor GPR30 inhibits proliferation of estrogen receptor-positive breast cancer cells.
    Ariazi EA; Brailoiu E; Yerrum S; Shupp HA; Slifker MJ; Cunliffe HE; Black MA; Donato AL; Arterburn JB; Oprea TI; Prossnitz ER; Dun NJ; Jordan VC
    Cancer Res; 2010 Feb; 70(3):1184-94. PubMed ID: 20086172
    [TBL] [Abstract][Full Text] [Related]  

  • 19. p53 status influences response to tamoxifen but not to fulvestrant in breast cancer cell lines.
    Fernandez-Cuesta L; Anaganti S; Hainaut P; Olivier M
    Int J Cancer; 2011 Apr; 128(8):1813-21. PubMed ID: 20549698
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Fulvestrant-induced cell death and proteasomal degradation of estrogen receptor α protein in MCF-7 cells require the CSK c-Src tyrosine kinase.
    Yeh WL; Shioda K; Coser KR; Rivizzigno D; McSweeney KR; Shioda T
    PLoS One; 2013; 8(4):e60889. PubMed ID: 23593342
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 23.